View in EDS HTML Full Text PDF Full Text

Levosimendan to Facilitate Weaning From ECMO in Patients With Severe Cardiogenic Shock: The LEVOECMO Randomized Clinical Trial.

Saved in:
Bibliographic Details
Title: Levosimendan to Facilitate Weaning From ECMO in Patients With Severe Cardiogenic Shock: The LEVOECMO Randomized Clinical Trial.
Authors: Combes, Alain1,2 alain.combes@aphp.fr, Saura, Ouriel1,2, Nesseler, Nicolas3, Lebbah, Said4, Rozec, Bertrand5,6, Levy, Bruno7,8,9, Fellahi, Jean-Luc10,11, Beurton, Antoine12,13, Meslin, Simon14, Gaudard, Philippe15, Bouglé, Adrien16,17, Vincentelli, André18, Sonneville, Romain19,20, Lebreton, Guillaume1,21, Lévy, David1,2, Ouattara, Alexandre12,13, Tubach, Florence4,22
Source: JAMA: Journal of the American Medical Association. 1/6/2026, Vol. 335 Issue 1, p60-69. 10p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:00987484
DOI:10.1001/jama.2025.19843